Strategies for improving the postmortem neuropathological diagnosis of Alzheimer's disease

Neurobiology of Aging

Volumn 18, Issue 4 SUPPL., 1997, Pages

  Trojanowski, J Q ^a   Clark, C M ^a   Schmidt, M L ^a   Arnold, S E ^a   Lee, V M Y ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Amyloid plaques; Neurofibrillary lesions; Paired helical filaments; PHFtau; Tau; amyloid

Indexed keywords

AMYLOID BETA PROTEIN; TAU PROTEIN;

ALZHEIMER DISEASE; AUTOPSY; COGNITIVE DEFECT; DEGENERATIVE DISEASE; HUMAN; NEUROFIBRILLARY TANGLE; NEUROPATHOLOGY; PAIRED HELICAL FILAMENT; PHENOTYPE; PRIORITY JOURNAL; REVIEW; SENILE PLAQUE;

EID: 0030668422     PISSN: 01974580     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0197-4580(97)00075-4     Document Type: Article

References (44)

1. Alzheimer A. Ueber eine eigenartige Erkrankung der Hirnrinde. Allgemeine Zeitschrift Psychiatrie Psychisch-Gerichtliche Med. 64:1907;146-148.
2. Arai H., Lee V. M. -Y., Otvos L. Jr, Greenberg B., Lowery D. E., Sharma S. K., Schmidt M. L., Trojanowski J. Q. Defined neurofilament, τ, and β-amyloid precursor protein epitopes distinguish Alzheimer from Non-Alzheimer senile plaques. Proc. Natl. Acad. Sci. USA. 87:1990;2249-2253.
3. Arai H., Schmidt M. L., Lee V. M. -Y., Hurtig H. I., Greenberg B. D., Adler C., Trojanowski J. Q. Epitope analysis of senile plaque components in the hippocampus of patients with Parkinson's disease. Neurology. 42:1992;1315-1322.
4. Arai H., Terajima M., Miura M., Higuchi S., Muramatsu T., Machida N., Seiki H., Takase S., Clark C. M., Lee V. M. -Y., Trojanowski J. Q., Sasaki H. Tau in cerebrospinal fluid A potential diagnostic marker of Alzheimer's disease . Ann. Neurol. 38:1995;649-652.
5. Arriagada P. A., Growdon J. H., Hedley-White E. T., Hyman B. T. Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease. Neurology. 42:1992;631-639.
6. Bancher C., Jellinger K. A. Neurofibrillary tangle predominant form of senile dementia of Alzheimer type A rare subtype in very old subjects . Acta Neuropathol. 88:1994;565-570.
7. Bierer L. M., Hof P. R., Purohit D. P., Carlin L., Schmeidler J., Davis K. L., Perl D. P. Neocortical neurofibrillary tangles correlate with dementia severity in Alzheimer's disease. Arch. Neurol. 52:1995;81-88.
8. Braak H., Braak E. Neuropathological staging of Alzheimer-related changes. Acta Neuropathol. 82:1991;239-259.
9. Buee-Scherrer V., Buee L., Hof P. R., Leveugle B., Gilles C., Loerzel A. J., Perl D. P., Delacourte A. Neurofibrillary degeneration in amyotrophic lateral sclerosis/parkinsonism-dementia complex of Guam Immunochemical characterization of tau proteins . Am. J. Pathol. 68:1995;924-932.
10. Cummings B. J., Pike C. J., Shankle R., Cotman C. W. β-amyloid deposition and other measures of neuropathology predict cognitive status in Alzheimer's disease. Neurobiol. Aging. 17:1966;921-933.
11. Dickson D. W., Crystal H. A., Mattiace L. A., Masur D. M., Blau A. D., Davies P., Yen S. -H., Aronson M. Identification of normal and pathological aging in prospectively studied nondemented elderly humans. Neurobiol. Aging. 13:1991;179-189.
12. Gearing M., Mirra S. S., Hedreen J. C., Sumi S. M., Hansen L. A., Heyman A. The consortium to establish a registry for Alzheimer's disease (CERAD). Part X Neuropathology confirmation of the clinical diagnosis of Alzheimer's disease . Neurology. 45:1995;461-466.
13. Goedert M., Trojanowski J. Q., Lee V. M. -Y. The neurofibrillary pathology of Alzheimer's disease. Prusiner S. B., Rosenberg R. N., Di Mauro S., Barchi R. L. The molecular and genetic basis of neurological disease. second edition. 1997;613-628 Butterworth Heineman Press, Boston, MA.
14. Hock C., Golomboswki S., Naser W., Mueller-Spahn F. Increased levels of τ in cerebrospinal fluid of patients with Alzheimer's disease - Correlation with degree of cognitive impairment. Ann. Neurol. 183:1995;43-45.
15. Hof P. R., Nimchinsky E. A., Buee-Scherrer V., Buee L., Nasrallah J., Hottinger A. F., Purohit D. P., Loerzel A. J., Steele J. C., Delacourte A., Bouras C., Morrison J. H., Perl D. P. Amyotrophic lateral sclerosis/parkinsonism-dementia complex of Guam Quantitative neuropathology, immunohistochemical analysis of neuronal vulnerability, and comparison with related neurodegenerative disorders . Acta Neuropathol. 88:1994;397-404.
16. Iwatsubo T., Odaka A., Suzuki N., Mizusawa H., Nukina N., Ihara Y. Visualization of Aβ 42(43)-positive and Aβ 40-positive senile plaques with end-specific Aβ-monoclonal antibodies Evidence that an initially deposited Aβ species is Aβ 1-42(43) . Neuron. 13:1994;45-53.
17. Iwatsubo, T.; Saido, T.; Mann, D. M. A.; Lee, V. M. -Y.; Trojanowski, J. Q. Full-length Aβ[1-42(43)] as well as amino-terminally modified and truncated Aβ42(43) deposit in diffuse plaques. Am. J. Pathol. 1823-1830; 1996.
18. Jensen M., Basum H., Lannfelt L. Increased cerebrospinal fluid tau in patients with Alzheimer's disease. Neurosci. Lett. 186:1995;189-191.
19. Khachaturian Z. S. Diagnosis of Alzheimer's disease. Arch. Neurol. 42:1985;1097-1106.
20. Levy-Lahad E., Wasco W., Poorkaj P., Romano D. M., Oshima J., Pettingell W. H., Yu C., Jondro P. D., Schmidt S. D., Wang K., Crowley A. C., Fu Y. -H., Guenett S. Y., Galas D., Nemens E., Wijsman E. M., Bird T. D., Schellenberg G. D., Tanzi R. E. Candidate gene for the chromosome 1 familial Alzheimer's disease locus. Science. 269:1995;973-977.
21. Marder, K.; Tang, M. -X.; Cote, L.; Stern, Y.; Mayeux, R. The frequency and associated risk factors for dementia in patients with Parkinson's disease. Arch. Neurol. 52:695-701. 138; 1995.
22. Mawal-Dewan M., Schmidt M. L., Balin B., Perl D., Lee V. M. -Y., Trojanowski J. Q. Identification of phosphorylation sites in PHF-tau from patients with Guam amyotrophic lateral sclerosis/parkinsonism-dementia complex. J. Neuropath. Exper. Neurol. 55:1996;1051-1059.
23. McKee A. C., Kosik K. S., Kowall N. W. Neuritic pathology and dementia in Alzheimer's disease. Ann. Neurol. 30:1991;156-165.
24. McKeith I. G., Galasko D., Kosaka K., Perry E. K., Dickson D. W., Hansen L. A., Salmon D. P., Lowe J., Mirra S. S., Byrne E. J., Lennox G., Quinn N. P., Edwardson J. A., Ince P. G., Bergeron C., Burns A., Miller B. L., Lovestone S., Collerton D., Jansen E. N. H., Ballard C., de Vos R. A. I., Wilcock G. K., Jellinger K. A., Perry R. H. Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB) Report on the consortium on DLB international workshop . Neurology. 47:1996;113-1124.
25. Mirra S. S., Heyman A., McKeel D., Sumi S. M., Crain B. J., Brownlee L. M., Vogel F. S., Hughes J. P., van Belle G., Berg L. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). II Standardization of the neuropathological assessment of Alzheimer's disease . Neurology. 41:1991;479-486.
26. Mori H., Hosoda K., Matsubara E., Nakamoto T., Furiya Y., Endoh R., Usami M., Shoji M., Maruyama S., Hirai S. Tau in cerebrospinal fluids Establishment of the sandwich ELISA with antibody specific to the repeat sequence in tau . Neurosci. Lett. 186:1995;181-183.
27. 42 in the cerebrospinal fluid of patients with Alzheimer's disease. Ann. Neurol. 38:1995;643-648.
28. Munroe W. A., Southwick P. C., Chang L., Scharre D. W., Exhols C. L., Fu P. C., Whaley J. M., Wolfert R. L. Tau protein in cerebrospinal fluid as an aid in the diagnosis of Alzheimer's disease. Ann. Clin. Lab. Sci. 25:1995;207-217.
29. The National Institute on Aging and Reagan Institute Working Group on Diagnostic Criteria for the Neuropathological Assessment of Alzheimer's Disease. Consensus recommendations for the postmortem diagnosis of Alzheimer's disease. Neurobiol. Aging 18(Suppl 1): S1-S2.
30. Nitsch R. M., Rebeck G. W., Deng M., Richardson I., Tennis M., Shenk D. B., Vigo-Pelfrey C., Lieberburg I., Wurtman R. J., Hyman B. T., Growdon J. H. Cerebrospinal fluid levels of amyloid β-protein in Alzheimer's disease Inverse correlation with severity of dementia and effect of apolipoprotein E genotype . Ann. Neurol. 37:1995;512-518.
31. Pollanen M. S., Dickson D. W., Bergeron B. Pathology and biology of the Lewy body. J. Neuropath. Exper. Neurol. 52:1993;183-191.
32. N3(pE), in senile plaques. Neuron. 14:1995;1-20.
33. Saunders A. M., Strittmatter W. J., Schmechel D., St George-Hyslop P. H., Pericak-Vance M. A., Joo S. H., Rosi B. L., Gusella J. F., Crapper-MacLachlan D. R., Alberts M. J., Hulette C., Crain B., Goldgaber D., Roses A. D. Association of apolipoprotein E allele ε 4 with late-onset familial and sporadic Alzheimer's disease. Neurology. 43:1994;1467-1472.
34. Schmidt M. L., DiDario A. G., Otvos L. Jr, Hoshi N., Kant A., Lee V. M. -Y., Trojanowski J. Q. Plaque-associated neuronal proteins A recurrent motif in neuritic amyloid deposits throughout diverse cortical areas of the Alzheimer's disease brain . Exp. Neurol. 130:1994;311-322.
35. Schwab C., Steele J. C., Akiyama H., McGeer E. G., McGeer P. L. Relationship of amyloid β/A4 protein to the neurofibrillary tangles in Guamanian parkinson-dementia. Acta Neuropathol. 90:1995;287-298.
36. Selkoe D. J. Normal and abnormal biology of the β-amyloid precursor protein. Annu. Rev. Neurosci. 17:1994;489-517.
37. Sherrington R., Rogaev E. I., Liang Y., Rogaev E. A., Levesque G., Ikeda M., Chi H., Lin C., Li G., Holman K., Tsuda T., Mar L., Foncin J. -F., Bruni A. C., Montesi M. P., Sorbi S., Rainero I., Pinessi L., Nee L., Chumakov I., Pollen D., Brookes A., Sanseau P., Polinsky R. J., Wasco W., Da Silva H. A. R., Haines J. L., Pericak-Vance M. A., Tanzi R. E., Roses A. D., Fraser P. E., Rommens J. M., St. George-Hyslop P. H. Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease. Nature. 375:1995;754-760.
38. Sumi S. M., Bird T. D., Nochlin D., Raskind M. Familial presenile dementia with psychosis associated with cortical neurofibrillary tangles and degeneration of the amygdala. Neurol. 42:1992;120-127.
39. Trojanowski J. Q., Lee V. M. -Y. Phosphorylation of neuronal cytoskeletal proteins in Alzheimer's disease and Lewy body dementias. Ann. New York Acad. Sci. 747:1994;92-109.
40. Trojanowski J. Q., Clark C. M., Arai H., Lee V. M. -Y. Elevated levels of tau in cerebrospinal fluid Implications for the antemortem diagnosis of Alzheimer's disease . Alzheimer's Disease Rev. 1:1996;77-83.
41. Ulrich J., Spillantini M. G., Goedert M., Dukas L., Staehlin H. B. Abundant neurofibrillary tangles without senile plaques in a subset of patients with senile dementia. Neurodegen. 1:1991;257-264.
42. Vigo-Pelfrey C., Seubert P., Barbour R., Blomquist C., Lee M., Lee D., Coria F., Chang L., Miller B., Lieberburg I., Shenk D. Elevation of microtubule-associated protein tau in the cerebrospinal fluid of patients with Alzheimer's disease. Neurol. 45:1995;788-793.
43. Wisniewski K., Jervis G. A., Moretz R. C., Wisniewski H. M. Alzheimer neurofibrillary tangles in disease other than senile and presenile dementia. Ann. Neurol. 5:1979;288-294.
44. Wisniewski T., Ghiso J., Frangione B. Alzheimer's disease and soluble Aβ Neurobiol. Aging. 15:1994;143-152.